Paul Leger
Papers
1
Total Citations
1
H-Index
1
About
Dr. Paul Leger is a clinician-researcher whose work centers on optimizing treatment outcomes and quality of life for men with localized prostate cancer. His major contributions lie at the intersection of radiation oncology and hormonal therapy, particularly in understanding and mitigating the side effects of androgen deprivation therapy (ADT). In his notable 2024 study, "Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer," Dr. Leger systematically characterized the prevalence and burden of hot flashes—a common yet underappreciated ADT side effect—during and after stereotactic body radiotherapy. This work provides critical data to help clinicians counsel patients and manage symptoms proactively. While his citation count is still growing, reflecting the early stage of his impactful research career, Dr. Leger’s focus on patient-reported outcomes and treatment tolerability marks him as a promising voice in improving survivorship care. His research bridges the gap between aggressive cancer control and the real-world experiences of patients, making him a valuable contributor to the field of genitourinary oncology.
Research Focus
Key Achievements
Top Papers
- 1